Articles
Managing Risks With Potent Pharmaceutical Products
As a noticeable shift occurs in the pharmaceutical industry from blockbuster drugs to smaller patient populations, there is an increased focus on targeted therapies in specialized areas, such as oncology, where potent compounds serve a key role in patient...
Articles
Redefining outsourcing: How the CDMO sector is reshaping its business
An ageing population, patent expirations, growth of disease prevalence, and expensive breakthrough therapies are driving demand for the development of many new pharmaceutical products. These growing pressures mean that pharmaceutical developers are faced with rising R&D costs and the...
Articles
Cold Chain Logistics: Powering Asia’s Biopharma Boom
As Asia’s healthcare systems mature, demand for the latest bio-pharmaceutical medicines is soaring. Most of these medicines are highly sensitive to temperature, meaning reliable cold chain services are crucial for effectively deploying biopharma across the region.
And the need for...
Interviews
The pharmaceutical supply chain: A digital future starts now
As TraceLink announces its Digital Network Platform aimed at transforming the global pharmaceutical supply chain to improve business performance and become more patient centric, we spoke to John Hogan, SVP, Engineering about digital supply chain strategies, the impact of...
Articles
How modern analytical instruments and intelligent software are accelerating metabolite identification in drug discovery and development
Intelligent technologies are transforming the pharmaceutical industry at a company and sector level, where tools such as artificial intelligence, machine learning and blockchain are pushing the limits of data analysis and accelerating decision-making. Meanwhile, similar technological progress is also...
Articles
The increase in global demand for in vitro performance testing models for topical products
The most common way to deliver a drug is systemically via an oral tablet or injection. In many cases, delivery of a drug via these routes may not be possible (poor bioavailability) or desirable (due to side effects); In...
Articles
Particle analysis: Growing demand with biologics
The development and introduction of new biological drug substances has been on the rise, and so have the regulatory requirements placed on these often life-saving products. At the same time, innovative analytical technologies have been developed that offer new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
